MYNX CADENCE VASCULAR CLOSURE DEVICE 6/7F
Report
- Report Number
- 3004939290-2012-00197
- Event Type
- Injury
- Date Received
- July 10, 2012
- Date of Event
- February 23, 2012
- Report Date
- June 11, 2012
- Manufacturer
- ACCESSCLOSURE, INC.
- Product Code
- MGB
- PMA / PMN Number
- P040044
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- PHYSICIAN
Narratives
THE DEVICE WAS NOT RETURNED; THEREFORE, A PHYSICAL INVESTIGATION COULD NOT BE PERFORMED. BASED ON THE INFO PROVIDED AND NO RETURNED DEVICE FOR PHYSICAL INVESTIGATION, THE REPORTED EVENT COULD NOT BE CONFIRMED AND THE ROOT CAUSE COULD NOT BE DETERMINED. THE REVIEW OF THE LHR (LOT F1133902) INDICATED THAT THE MYNX LOT MET ALL ESTABLISHED PERFORMANCE CRITERIA PRIOR TO SHIPMENT.
IT WAS REPORTED BY THE ACI VASCULAR CLOSURE SPECIALIST THAT A PT UNDERWENT A CATHETERIZATION PROCEDURE ON (B)(6) 2012 AT 12:41. ACCESS WAS OBTAINED AT THE RIGHT FEMORAL ARTERY. FOLLOWING THE PROCEDURE, THE PHYSICIAN SELECTED THE MYNX CADENCE VASCULAR CLOSURE DEVICE 6/7F TO CLOSE THE ACCESS SITE. AT 13:02 THE DEVICE WAS DEPLOYED. MANUAL PRESSURE WAS APPLIED FOR 15 MINS FOR HEMOSTASIS. THE PT'S RIGHT GROIN WAS DOCUMENTED AS UNREMARKABLE AND WITH NO BLEEDING. AT 13:28 A FEMOSTOP WAS APPLIED AT THE RIGHT GROIN, AT PRESSURE 60. AT 13:53 THE PT WAS TRANSFERRED TO THE CVICU ROOM. THE FEMOSTOP PRESSURE WAS DECREASED TO 50 AND THE PT'S GROIN SITE BEGAN TO BLEED. PRESSURE WAS HELD AT THE ACCESS SITE. THE PT'S SYS BP DROPPED TO 70'S. AN IV BOLUS WAS GIVEN TO PT. A CT SCAN WAS ORDERED AND BLOOD TRANSFUSION WAS ORDERED. SYS BP WAS 110 AT 14:05. SYS BP WAS 159 AT 14:20 AND 124 AT 15:50. THE PT RECEIVED 4 U PRBCS BETWEEN (B)(6) 2012. A CT SCAN ON (B)(6) INDICATED AN ACUTE HEMATOMA PROX R THIGH 11.8 X 3.1 X 11.5 CM AND NO RETROPERITONEAL HEMATOMA.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | MYNX CADENCE VASCULAR CLOSURE DEVICE 6/7F | MGB | ACCESSCLOSURE, INC. | MX6701 | F1133902 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention | JANUVIA| ASA| HEPARIN| INTEGRILLIN |